# Replimune Group, Inc.: Form 8-K, filed Jun 13, 2024

- Company: [Replimune Group, Inc.](/companies/repl.md) (CIK 1737953)
- Form: 8-K
- Filed: 2024-06-13
- Accepted by EDGAR: Jun 13, 2024, 08:36 ET
- Period: 2024-06-12
- Accession: 0001104659-24-071078
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737953/000110465924071078/tm2417173d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737953/000110465924071078/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737953/000110465924071078/tm2417173d1_8k.htm

Filed Jun 13, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-071078. Last ingested by Listed: Nov 10, 2026, 04:35 ET. No prices; not investment advice.